Our mission is to become a worldwide reference for education in the field for all professionals involved in the process to disseminate knowledge & skills of Acute Cardiovascular Care.
Our mission is to promote excellence in clinical diagnosis, research, technical development, and education in cardiovascular imaging in Europe.
Our mission is to promote excellence in research, practice, education and policy in cardiovascular health, primary and secondary prevention.
Our mission is to reduce the burden of cardiovascular disease in Europe through percutaneous cardiovascular interventions.
Our mission is to improve the quality of life of the population by reducing the impact of cardiac rhythm disturbances and reduce sudden cardiac death.
Our mission is to improve quality of life and longevity, through better prevention, diagnosis and treatment of heart failure, including the establishment of networks for its management, education and research.
The ESC Working Groups' goal is to stimulate and disseminate scientific knowledge in different fields of cardiology.
The ESC Councils' goal is to share knowledge among medical professionals practising in specific cardiology domains.
OUR MISSION: TO REDUCE THE BURDEN OF CARDIOVASCULAR DISEASE
The ESC Working Group on Cardiovascular Pharmacology and Drug Therapy will hold its first congress on "New Trends in Cardiovascular Drug Therapy", from 7-8 June 2013, in the beautiful city of Rome.
The meeting will take place in the NH Vittorio Veneto Hotel, situated in the heart of the city, between the quiet grounds of Villa Borghese and the exclusive shopping and nightlife area around Via Veneto.Those two days meeting will highlight key issues in drug therapy, with high level presentations in the field.
Lipid lowering LDL and beyondAlberto Zambon (Padua – ITALY)
Diabetes – is there any reason to prefer the newer drugs?Juan Tamargo (Madrid – SPAIN)
The ESC Guidelines on Acute Coronary SyndromesMarco Tubaro (Rome – ITALY)
How to manage triple therapyStefan Agewall (Oslo – NORWAY)
How to implement medical therapy at dischargePasquale Perrone-Filardi (Naples – ITALY)
Chair Francesco Romeo (Rome – ITALY)Heinz Drexel (Feldkirch – AUSTRIA)
Heart rate reduction Claudio Ceconi (Ferrara – ITALY)
Modulation of cardiac metabolism in IHD Giuseppe Rosano (Rome – ITALY)
Optimal management of risk factors and diabetesSven Wassmann (Munich – Germany)
Putting ACE inhibitors, ARBs and Renin inhibitors into contextRoberto Ferrari (Ferrara – ITALY)
Chair: Faiez Zannad (Nancy – FRANCE)Harald Schmidt (Maastricht – THE NETHERLANDS)
The HFA/ESC Guidelines on the treatment of heart failure Stefan Anker (Berlin – GERMANY)
Devices for the management of heart failureSven Wassmann (Munich – GERMANY)
Pharmacotherapy in patients with devices Atul Patak (Toulouse – FRANCE)
Chair: Mihai Gheorghiade (Chicago – USA)Giuseppe Rosano (Roma – ITALY)
Faiez Zannad (Nancy – FRANCE) – Pieter de Graeff (Amsterdam – THE NETHERLANDS) – Luca Pani (Rome – ITALY)– Michael Mendelsohn (New York – USA) – Preston Dunnmon (Washington – USA)
© 2017 European Society of Cardiology. All rights reserved